首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
On October 2nd, Ashoka Mukpo left his father a voice mail from Monrovia, saying he had "unwelcome but not unexpected news. " Muk
On October 2nd, Ashoka Mukpo left his father a voice mail from Monrovia, saying he had "unwelcome but not unexpected news. " Muk
admin
2019-07-19
54
问题
On October 2nd, Ashoka Mukpo left his father a voice mail from Monrovia, saying he had "unwelcome but not unexpected news. " Mukpo, an American freelance camera-man for NBC News, had tested positive for Ebola virus. Mukpo’s father, Mitchell Levy, a pulmonologist who heads critical care at Rhode Island Hospital in Providence, immediately helped arrange his son’s transfer to the Nebraska Medical Center in Omaha, one of the four specialized Ebola centres in the United States.
The big question then was how to treat the patient.
The medical team, which included Levy, planned to intensively monitor Mukpo and give him intravenous replacement of fluids and electrolytes, antibiotics to combat also had three unproven treatments available. TKM-Ebola, which inhibits viral RNA, has worked beautifully in monkeys, the best animal model. Kent Brantly, a missionary doctor in Liberia who developed Ebola and recovered, offered to donate plasma removed from his blood, which contained antibodies that might help. And there was brincidofovir, a drug being developed for other viral infections that has been shown to stop Ebola virus in test tubes. The most famous drug candidate, ZMapp, was not available at the time. After careful consideration, Mukpo and his doctors opted to use the serum—a proven intervention with other viruses—and brincidofovir, which has a substantial safety record. But they decided to forgo TKM-Ebola, despite its promise, because of worries that it could trigger overproduction of cytokines, a dangerous inflammatory response also caused by the Ebola virus, and scant data from human trials. "I was not quite on my deathbed and didn’t need to take any huge risks," Mukpo says. His doctor father had reached a similar conclusion. "I didn’t have a high degree of confidence that brincidofovir was going to work, but I was loath to try an investigational agent with no data," Levy says.
Mukpo survived, but no one has any idea whether the experimental treatments helped him, did nothing, or even slowed his recovery. The same is true for Brandy and 17 other Ebola patients who received experimental interventions in the United States and Europe.(One other Ebola patient was treated in Germany without any experimental interventions.)Many, like Mukpo, were given several treatments at the same time, making it hard to unravel the impact of anyone of them. The fact that they were taken care of in modern, well-staffed hospitals may also help explain why 75 % have survived. "Probably the best we can say is that the experimental treatments are not killing anyone," says Michael Kurllla, who heads the Office of Biodefense Research Resources and Translational Research at the National Institute of Allergy and Infectious Diseases(NIAID)in Roekville, Maryland.
Now, that’s about to change. As early as next month, researchers will begin trials in West Africa to find a solid answer to the key question: Do the treatments work? Carried out in makeshift e-mergency hospitals by researchers wearing full protective gear in the middle of a deadly epidemic, these will be some of the most unusual drug trials ever done. And they also raise major ethical and practical questions, some of which were intensely debated at a World Health Organization(WHO)meeting in Geneva, Switzerland, on November 11th and 12th. Perhaps the most important one: Is it right to do randomized controlled trials(RCTs), in which some people don’t get the novel intervention ? Doctors without Borders(MSF), which has led the medical response to the outbreak, says no—not with a disease as deadly as Ebola. Instead, on November 13th MSF said it will take part in three trials that will use an alternative design in which everyone who enrolls receives the untested treatment. But others argue that such setups may not give clear answers and squander a precious scientific opportunity.
It’s an uncomfortable and complex debate held under extreme time pressure. " Everyone has stepped outside of their comfort zone in a big way," says Peter Horby of the University of Oxford in the United Kingdom, who is leading one of the upcoming trials and attended the WHO meeting.
Questions 66 to 70
Answer the following questions with the information given in the passage.
What is the objective of the trials conducted in West Africa?
选项
答案
To find out whether the treatment works.
解析
(答案在文中明确给出,参见第五段第二句“To find a solid answer to the key question:Dothe treatments work?”。)
转载请注明原文地址:https://kaotiyun.com/show/mQfK777K
本试题收录于:
A类竞赛(研究生)题库大学生英语竞赛(NECCS)分类
0
A类竞赛(研究生)
大学生英语竞赛(NECCS)
相关试题推荐
Themajorpartofmychildhoodwasspentinfightingoffterrorofthingswhichdidn’texist,andIdon’tthinkmyfatherever
Themajorpartofmychildhoodwasspentinfightingoffterrorofthingswhichdidn’texist,andIdon’tthinkmyfatherever
Themajorpartofmychildhoodwasspentinfightingoffterrorofthingswhichdidn’texist,andIdon’tthinkmyfatherever
Themajorpartofmychildhoodwasspentinfightingoffterrorofthingswhichdidn’texist,andIdon’tthinkmyfatherever
Themajorpartofmychildhoodwasspentinfightingoffterrorofthingswhichdidn’texist,andIdon’tthinkmyfatherever
WhenIwasateenager,I______alotandpeoplecouldn’tunderstandwhatIwassaying.
WhowasafoundingfatheroftheAmericanRepublic?
MyentryintoBlackwomen’shistorywasunexpectedbutagreeable.IntheprefacetoBlackWomeninAmerica:AnHistoricalEncycl
随机试题
对于输出设备的说法,不正确的是()。
设f(x)在闭区间[a,b]上连续,由定积分中值定理,在[a,b]上至少存在一点p,使得f(p)=______.
组织管理理论主要研究()。
关于胸膜间皮瘤,错误的是
患者腹泻1天,4~5次水样便,无明显里急后重。便常规:脓细胞0~2个/HP,红细胞1~3个/HP。涂片染色见革兰阴性弯曲且排列成鱼群状细菌,悬滴法见运动快的细菌。最大可能诊断是
某女工不慎将头发卷入机器,造成大面积头皮撕脱关于其创面的描述哪一项不正确
在钻孔桩施工质量控制中,对于嵌岩桩与摩擦桩指标要求不同的是()。
中国共产党第十八届中央委员会第()次全体会议于2014年10月20日至23日在北京召开。本次四中全会专题讨论()问题,这在党的历史上尚属首次。
下列句子中存在歧义的是()。
某单位向希望工程捐款,其中领导部门每人捐款50元,普通员工每人捐20元。某部门所有人员共计捐款320元,已知该部门总人数超过10人,问该部门可能有几名部门领导?()
最新回复
(
0
)